Aims Deciding to stop or continue anticoagulation for venous thromboembolism (VTE) after
initial treatment is challenging, as individual risks of recurrence and bleeding are …

Background Unprovoked first venous thromboembolism (VTE) is defined as VTE in the
absence of a temporary provoking factor such as surgery, immobility and other temporary …

Background: The decision to stop anticoagulation after an episode of venous
thromboembolism (VTE) depends on the risk of recurrence. A number of recently discussed …

Purpose In this study, we aimed to estimate recurrence risk after incident venous
thromboembolism, stratified according to unprovoked, provoked, and cancer-related venous …

Background: Whether to continue oral anticoagulant therapy beyond 6 months after an
“unprovoked” venous thromboembolism is controversial. We sought to determine clinical …

For patients with venous thromboembolism (VTE), prediction of bleeding is relevant
throughout the course of treatment, although the means and goal of this prediction differ …

Background Several models are available to predict recurrent venous thrombosis (VT) in
patients with unprovoked first events. Objectives To validate these prediction models …

The recommended treatment for patients with venous thromboembolism (VTE) is
anticoagulation for at least 3 months. However, anticoagulant treatment increases the risk of …

Venous thromboembolism (VTE) is a leading cause of morbidity and mortality and is
associated with high recurrence rates. The introduction of direct oral anticoagulants …

Introduction Patients with a first venous thromboembolism (VTE) are at risk of recurrence.
Recurrent VTE (rVTE) can be prevented by extended anticoagulant therapy, but this comes …